Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
NCT07489066
Bronchial Neoplasms, Carcinoma
Hinsdale, Illinois, United States
View Trial DetailsNCT Number: NCT07143110
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Interested in participating?
Request Info18 year–130 year
All sexes
Observational
Research Site, Calgary, Alberta, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, an average of 1 year
Time frame: Through study completion, an average of 1 year
Time frame: Through study completion, an average of 1 year
Time frame: Through study completion, an average of 6 months
Time frame: Through study completion, an average of 6 months
Time frame: Through study completion, an average of 1 year
Time frame: Through study completion, an average of 1 year
Time frame: Through study completion, an average of 1 year
Contact information is provided by the study sponsor or research team.
AstraZeneca
Industry
Acronym: LUNG-ROLL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07489066
Bronchial Neoplasms, Carcinoma
Hinsdale, Illinois, United States
View Trial DetailsNCT04577599
Behavior, Lung Cancer
Charlotte, North Carolina, United States
View Trial DetailsNCT06885697
Adenoma, Adnexal Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07476287
Bronchial Neoplasms, Carcinoma, Bronchogenic
Duarte, California, United States
View Trial Details